Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s stock price traded up 9.1% during mid-day trading on Tuesday . The stock traded as high as GBX 1.80 ($0.02) and last traded at GBX 1.80 ($0.02). 1,744,599 shares traded hands during trading, an increase of 4% from the average session volume of 1,670,021 shares. The stock had previously closed at GBX 1.65 ($0.02).
Cizzle Biotechnology Stock Up 12.7 %
The stock has a market cap of £8.93 million, a PE ratio of -225.40 and a beta of 0.38. The firm has a 50-day simple moving average of GBX 1.79 and a 200-day simple moving average of GBX 1.84.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Read More
- Five stocks we like better than Cizzle Biotechnology
- The Risks of Owning Bonds
- Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial
- What is a Low P/E Ratio and What Does it Tell Investors?
- Double-Digit Gains Ahead? These 2 Cybersecurity Stocks Look Ready
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Will Falling Bond Yields Send These 2 Small Caps Soaring?
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
